InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Explore the complete record of transactions filed by Lunger John, Directeur de l'Approvisionnement des Patients. Officer active across 1 companies, notably Adaptimmune Therapeutics PLC. Cumulatively, 10 filings have been logged. Total volume traded: €87k. The latest transaction was filed on 18 January 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
€12,2184,368 shares@ €2.797228.0% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-22-005055·
€12,2184,368 shares@ €2.797214.0% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-22-005055:0·
€11,8343,770 shares@ €3.139127.1% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-22-004152·
€11,8343,770 shares@ €3.139113.6% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-22-004152:0·
€3,8481,070 shares@ €3.59594.4% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-22-001670:0·
€3,8481,070 shares@ €3.59598.8% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-22-001670·
€8,8722,939 shares@ €3.018920.3% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-21-098959·
€8,8722,939 shares@ €3.018910.2% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-21-098959:0·
€6,8661,907 shares@ €3.600215.7% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-21-089048·
€6,8661,907 shares@ €3.60027.9% of flow
American Depositary Shares representing Ordinary Shares
SEC:0001104659-21-089048:0·
10 of 10 declarations
About Lunger John
John Lunger is the Chief Patient Supply Officer at Adaptimmune Therapeutics PLC. He is responsible for managing the supply and logistics of treatments for patients. John plays a key role in optimizing supply chain processes to ensure that patients receive necessary treatments in a timely manner. His expertise in supply chain management is crucial for the success of Adaptimmune's operations.
